CSIR-CCMB scientist gets Infosys award

Dr. Sankaranarayanan is the third scientist from the centre to get the prize in life sciences category

December 03, 2020 11:21 pm | Updated 11:21 pm IST - HYDERABAD

CSIR- Centre for Cellular and Molecular Biology (CCMB)’s Dr. Rajan Sankaranarayanan, a structural biologist studying structures of proteins in cells and how accuracy is maintained by cellular machinery while building proteins across evolution, has won the prestigious Infosys Prize 2020 for the life sciences category announced on Wednesday night.

“15 years back, when I proposed the question, people thought the question was non-existent. From then to now winning this prize, I feel having come a long way – thanks to all the support from family and colleagues,” said Dr. Sankaranarayanan

Director Dr. Rakesh Mishra said, “Dr. Sankaranarayanan is an extremely rigorous scientist, and is highly celebrated among his peers in India as well as internationally. All of us in the CCMB community are delighted at him winning the Infosys Prize this year.”

Proteins are made of amino acids which are present in our bodies in two forms – D and L forms, each a mirror image of the other. However, if D amino acids are incorporated in proteins being built, it can lead to many deleterious effects. The CCMB scientist has found mechanistic details of how such a fundamental process runs in our cells avoiding many possible errors.

It is the second Infosys prize for CCMB in life sciences in a row and in all it won three. Dr. Manjula Reddy won this prize last year in 2019 and Dr. Imran Siddiqui won it in 2011. A purse of US$ 1 lakh, citation and gold medal is given to the chosen one, a press release said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.